Physician profile
William M Quick
NPI 1659438950
$1,570.04
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $936 · 2020: $254 · 2021: $249 · 2022: $131.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $1,226.19 | 2019-2022 | |
| Allergan, INC. | $227.30 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.50 | 2019 | |
| Shire North American Group INC | $33.99 | 2019 | |
| Lundbeck LLC | $20.51 | 2019 | |
| Abbvie INC. | $17.55 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Quick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.